Dr. Ron WeinbergerNon-Executive Chairman
Ron is an experienced technology and business development executive, with a demonstrated history of building significant value at multiple levels in the medical device industry.
Dr. Weinberger is the former Executive Director and Chief Executive Officer of Nanosonics (ASX: NAN), an $800 million market cap healthcare company, and has over 20 years’ experience in developing and commercializing medical devices.
During his time at Nanosonics, Dr. Weinberger co-developed the Group’s platform technology, launched their breakthrough product Trophon globally and created the North American sales team to work alongside GE Healthcare. Ron also developed the distribution strategy for Europe having partnered with Toshiba Medical Systems (now Canon Medical Systems) and Miele Professional.
Dr. Weinberger was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialization success stories.
Dr. Weinberger holds a Ph.D. in Medical Biochemistry from the University of Newcastle and Bachelor of Science (Hons) in Molecular Pharmacology from the University of Sydney.